Switch from intravenous-to-oral antibiotics in neonatal probable and proven early-onset infection: a prospective population-based real-life multicentre cohort study.

Infant Welfare Infectious Disease Medicine Neonatology Sepsis

Journal

Archives of disease in childhood. Fetal and neonatal edition
ISSN: 1468-2052
Titre abrégé: Arch Dis Child Fetal Neonatal Ed
Pays: England
ID NLM: 9501297

Informations de publication

Date de publication:
27 Jun 2023
Historique:
received: 25 01 2023
accepted: 08 06 2023
medline: 28 6 2023
pubmed: 28 6 2023
entrez: 27 6 2023
Statut: aheadofprint

Résumé

To evaluate the implementation of switch from intravenous-to-oral antibiotic therapy with amoxicillin in neonates with early-onset infection (EOI). A population-based multicentre cohort study. All term-born neonates with EOI were prospectively included between 1 December 2018 to 30 November 2020. Intravenous-to-oral switch antibiotic therapy in clinically stable neonates. The primary outcome was readmission due to infection. Secondary outcomes were days of hospitalisation and antibiotic use in the pre-implementation versus post implementation period. During 2 years, 835 neonates commenced antibiotics for EOI (1.5% (95% CI 1.4% to 1.6%)) of all term live births). Of those, 554 (66%) underwent a full course of treatment. There were 23 episodes of culture-proven infection (0.42 per 1000 term live births (95% CI 0.27 to 0.63)). A total of 478 of 531 (90%) neonates with probable infection underwent switch therapy. None was readmitted due to infection. The median duration of hospitalisation was 3.0 days (IQR 2.5-3.5) and 7.4 days (IQR 7.0-7.5) in the switch and intravenous therapy groups, respectively. According to antibiotic surveillance data, 1.2% underwent a full course of treatment following implementation of oral switch therapy (2019-2020), compared with 1.2% before (2017-2018). In clinical practice, switch therapy was safe and used in 9 of 10 neonates with probable EOI. Knowledge of the safety of antibiotic de-escalation is important as home-based oral therapy ameliorates the treatment burden for neonates, caregivers and healthcare systems. Despite the ease of oral administration, implementation of switch therapy did not increase the overall use of antibiotics.

Identifiants

pubmed: 37369601
pii: archdischild-2023-325386
doi: 10.1136/archdischild-2023-325386
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Emma Louise Malchau Carlsen (EL)

Department of Neonatology, Rigshospitalet, University of Copenhagen, Kobenhavn, Denmark emma.louise.malchau.carlsen@regionh.dk.
Department of Pediatrics, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark.

Kia Hee Schultz Dungu (KHS)

Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Kobenhavn, Denmark.

Anna Lewis (A)

Department of Pediatrics, Hillerød Hospital, University of Copenhagen, Hillerod, Denmark.

Nadja Hawwa Vissing (NH)

Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Kobenhavn, Denmark.

Lise Aunsholt (L)

Department of Neonatology, Rigshospitalet, University of Copenhagen, Kobenhavn, Denmark.
Comparative Pediatrics and Nutrition, University of Copenhagen, Copenhagen, Denmark.

Simon Trautner (S)

Department of Neonatology, Rigshospitalet, University of Copenhagen, Kobenhavn, Denmark.

Hristo Stanchev (H)

Department of Pediatrics, Slagelse Hospital, Slagelse, Denmark.

Gholamreza Krog Dayani (GK)

Department of Pediatrics and Adolescence, Roskilde Hospital, Roskilde, Denmark.

Anne-Janet L Pedersen (AL)

Department of Pediatrics, Nykøbing F Sygehus, Nykobing, Denmark.

Mia Bjerager (M)

Department of Pediatrics, Hillerød Hospital, University of Copenhagen, Hillerod, Denmark.

Maria De Salas (M)

Department of Pediatrics, Herlev Hospital, University of Copenhagen, Herlev, Denmark.

Kristian Vestergaard (K)

Department of Pediatrics, Holbaek Sygehus, Holbaek, Denmark.

Pernille Pedersen (P)

Department of Pediatrics, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark.

Niels Frimodt-Møller (N)

Department of Microbiology, Rigshospitalet, University of Copenhagen, Kobenhavn, Denmark.

Gorm Greisen (G)

Department of Neonatology, Rigshospitalet, University of Copenhagen, Kobenhavn, Denmark.
Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Kobenhavn, Denmark.

Bo Mølholm Hansen (BM)

Department of Pediatrics, Hillerød Hospital, University of Copenhagen, Hillerod, Denmark.
Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Kobenhavn, Denmark.

Ulrikka Nygaard (U)

Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Kobenhavn, Denmark.
Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Kobenhavn, Denmark.

Classifications MeSH